[{"Assets_0_Q2_USD":"1360300000.0","CIK":"899923","CommonStockSharesConverted_0_Q2_shares":"77700000.0","CommonStockSharesOutstanding_0_Q2_shares":"77700000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.06","EarningsPerShareBasic_2_Q2_USD":"-0.58","EarningsPerShareDiluted_1_Q2_USD":"-0.06","EarningsPerShareDiluted_2_Q2_USD":"-0.58","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q2_USD":"-100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"67400000.0","NetIncomeLoss_1_Q2_USD":"-4700000.0","NetIncomeLoss_2_Q2_USD":"-44200000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q2_USD":"-4700000.0","ProfitLoss_2_Q2_USD":"-44200000.0","RevenuesConverted_1_Q2_USD":"189400000.0","RevenuesConverted_2_Q2_USD":"362500000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"902400000.0","StockholdersEquity_0_Q2_USD":"902500000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"77200000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"76600000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"77200000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"76600000.0","filed":"20210804","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"MYRIAD GENETICS INC","period":"20210630","qtrs":"2","uom":"USD"}]